Desh Rakshak Aushdhalaya Ltd
₹ 39.6
-1.98%
23 May
- close price
About
Incorporated in 1901, Desh Rakshak Aushdhalaya Ltd manufactures Ayurvedic and Herbal Products[1]
Key Points
- Market Cap ₹ 17.6 Cr.
- Current Price ₹ 39.6
- High / Low ₹ 41.5 / 7.65
- Stock P/E 33.9
- Book Value ₹ 21.8
- Dividend Yield 0.00 %
- ROCE 6.83 %
- ROE 4.62 %
- Face Value ₹ 10.0
Pros
- Company's working capital requirements have reduced from 141 days to 109 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 1.55% over past five years.
- Company has a low return on equity of 4.97% over last 3 years.
- Company has high debtors of 315 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.82 | 3.97 | 4.44 | 4.98 | 5.05 | 5.05 | 5.51 | 5.06 | 6.56 | 6.14 | 6.13 | 5.95 | 6.64 | |
| 3.58 | 3.39 | 3.79 | 4.26 | 4.39 | 4.34 | 4.73 | 4.27 | 5.61 | 4.94 | 4.74 | 4.66 | 5.32 | |
| Operating Profit | 0.24 | 0.58 | 0.65 | 0.72 | 0.66 | 0.71 | 0.78 | 0.79 | 0.95 | 1.20 | 1.39 | 1.29 | 1.32 |
| OPM % | 6.28% | 14.61% | 14.64% | 14.46% | 13.07% | 14.06% | 14.16% | 15.61% | 14.48% | 19.54% | 22.68% | 21.68% | 19.88% |
| 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | -0.05 | 0.02 | 0.02 | |
| Interest | 0.05 | 0.08 | 0.12 | 0.11 | 0.11 | 0.13 | 0.13 | 0.16 | 0.16 | 0.24 | 0.42 | 0.37 | 0.30 |
| Depreciation | 0.16 | 0.39 | 0.45 | 0.24 | 0.22 | 0.24 | 0.25 | 0.27 | 0.26 | 0.40 | 0.44 | 0.44 | 0.44 |
| Profit before tax | 0.03 | 0.12 | 0.08 | 0.38 | 0.34 | 0.35 | 0.41 | 0.37 | 0.55 | 0.57 | 0.48 | 0.50 | 0.60 |
| Tax % | 133.33% | 41.67% | 75.00% | 23.68% | 17.65% | 20.00% | 19.51% | 18.92% | 23.64% | 15.79% | 14.58% | 16.00% | |
| 0.00 | 0.07 | 0.02 | 0.29 | 0.28 | 0.28 | 0.34 | 0.30 | 0.42 | 0.48 | 0.41 | 0.43 | 0.52 | |
| EPS in Rs | 0.00 | 0.16 | 0.05 | 0.65 | 0.63 | 0.63 | 0.77 | 0.68 | 0.95 | 1.08 | 0.92 | 0.97 | 1.17 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 2% |
| 3 Years: | -3% |
| TTM: | 28% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 5% |
| 3 Years: | 1% |
| TTM: | 24% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | % |
| 3 Years: | 110% |
| 1 Year: | 444% |
| Return on Equity | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 5% |
| 3 Years: | 5% |
| Last Year: | 5% |
Balance Sheet
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 |
| Reserves | 2.06 | 2.13 | 2.15 | 2.46 | 2.74 | 3.02 | 3.45 | 3.72 | 4.14 | 4.62 | 4.47 | 4.82 | 5.03 |
| 0.93 | 0.99 | 1.06 | 1.47 | 0.69 | 0.96 | 1.23 | 2.03 | 2.90 | 4.31 | 4.10 | 2.78 | 3.38 | |
| 1.65 | 1.55 | 1.71 | 1.49 | 2.07 | 2.16 | 2.01 | 1.91 | 2.87 | 2.53 | 2.51 | 4.06 | 3.59 | |
| Total Liabilities | 9.30 | 9.33 | 9.58 | 10.08 | 10.16 | 10.80 | 11.35 | 12.32 | 14.57 | 16.12 | 15.74 | 16.32 | 16.66 |
| 3.61 | 3.61 | 3.69 | 3.75 | 3.87 | 3.93 | 4.39 | 5.38 | 6.49 | 7.82 | 8.07 | 7.68 | 7.48 | |
| CWIP | 1.35 | 1.35 | 1.35 | 2.37 | 2.37 | 2.37 | 2.37 | 2.37 | 2.37 | 2.37 | 2.37 | 2.37 | 2.37 |
| Investments | 0.18 | 0.18 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| 4.16 | 4.19 | 4.42 | 3.84 | 3.80 | 4.38 | 4.47 | 4.45 | 5.66 | 5.88 | 5.25 | 6.22 | 6.76 | |
| Total Assets | 9.30 | 9.33 | 9.58 | 10.08 | 10.16 | 10.80 | 11.35 | 12.32 | 14.57 | 16.12 | 15.74 | 16.32 | 16.66 |
Cash Flows
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.18 | 0.46 | 0.27 | 1.27 | 0.23 | -0.15 | -0.55 | 0.59 | 0.84 | 0.23 | 0.45 | 1.52 | |
| -0.02 | -0.33 | -0.45 | -0.66 | -0.76 | 0.04 | 0.42 | -1.27 | -1.26 | -1.95 | -0.78 | -0.09 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.00 | 0.74 | 0.80 | 1.35 | 0.15 | -1.34 | |
| Net Cash Flow | 0.16 | 0.13 | -0.18 | 0.61 | -0.53 | -0.04 | -0.12 | 0.06 | 0.37 | -0.36 | -0.18 | 0.09 |
Ratios
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 191.10 | 117.68 | 127.42 | 125.33 | 146.72 | 179.25 | 196.08 | 221.45 | 214.77 | 236.00 | 216.74 | 314.70 |
| Inventory Days | 111.22 | 225.14 | 215.33 | 160.82 | 191.55 | 193.41 | 120.33 | 123.23 | 72.16 | 117.52 | 107.51 | 43.45 |
| Days Payable | 241.24 | 250.72 | 247.41 | 195.79 | 242.83 | 257.39 | 219.27 | 249.57 | 270.87 | 315.23 | 301.29 | 551.85 |
| Cash Conversion Cycle | 61.08 | 92.10 | 95.35 | 90.37 | 95.44 | 115.26 | 97.14 | 95.11 | 16.06 | 38.29 | 22.96 | -193.70 |
| Working Capital Days | 211.16 | 202.27 | 203.05 | 109.94 | 117.81 | 148.89 | 153.02 | 162.30 | 117.40 | 164.07 | 149.45 | 108.58 |
| ROCE % | 1.06% | 2.59% | 2.56% | 5.95% | 5.40% | 5.74% | 6.01% | 5.37% | 6.42% | 6.41% | 7.08% | 6.83% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
7 May - Of Para A of Part A of Schedule III read with Regulation 30 of the SEBI (LODR) Regulations, 2015, please find enclosed advertisement published in …
-
INTIMATION FOR CUT OFF DATE/RECORD DATE
5 May - Record date set as May 22, 2025 for voting rights in EGM on May 29, 2025.
-
INFORMATION ABOUT CLOSURE OF THE REGISTER OF MEMBERS AND THE SHARE TRANSFER BOOKS
5 May - Book closure from May 23-29, 2025 for EGM; remote e-voting May 26-28, 2025.
- Submission Of Certificate In Respect Of Compliance Of Regulation 165 Of The SEBI (ICDR) Reg, 2018 For Issue And Allotment Of 12,60,000 Equity Shares Of The Face Value Of Rs.10/-Each On Preferential Basis 5 May
- Submission Of Certificate Of PCS In Respect Of Compliance Of SEBI (ICDR) Reg, 2018 For Issue And Allotment Of 12,60,000 Equity Shares Of The Face Value Of Rs.10 Each On Preferential Basis Under Reg 28(1) Of The SEBI (LODR), Reg, 2015 5 May
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
-
Financial Year 2008
from bse
Business Overview:[1][2]
DRAL is the flagship company of Bhagwant Group and one of the oldest manufacturers of Pure Ayurvedic and Herbal Products. It has a wide range of ethical medicines that are derived from herbs and form part of this holistic healthcare system. The medicines are categorized into Proprietary & Classical Medicines. The company is currently manufacturing around 450 products which are GMP certified.